- Therapeutic Antibodies & Biosimilar ELISA Kits
- Anti-Adalimumab (Humira®) ADA Quantitative ELISA Kit
Anti-Adalimumab (Humira®) ADA Quantitative ELISA Kit
Enzyme immunoassay for the quantitative determination of antibodies to adalimumab in serum and plasma with confirmation. Adalimumab (Humira®) was associated to the development of anti-Adalimumab antibodies, even some were reported to be neutralizing, in various percentages of patients during therapy with the drug Humira®. This might lead to severe complications. The ELISA Genie Antibody to Adalimumab ELISA Kit can be efficiently used for monitoring anti-Adalimumab antibodies during therapy and offers the clinician a tool for decision on possible preventive measures such as possible addition of immunosuppressive drug to reduce anti-Adalimumab antibodies.
|Required Volume (μl)||10|
|Total Time (min)||140|
|Sample Type||Serum, Plasma|
|Number of Assays||96|
|Detection Limit (ng/mL)||30 (ng/mL)|
|Spike Recovery (%)||85-115%|
|Shelf Life (year)||1|
About Anti-Adalimumab (Humira®) ADA Quantitative
Anti-Adalimumab (Humira®) ADA Quantitative ELISA Kit test principle
Humira® is a registered trademark of AbbVie Biotechnology, Inc.